:quality(85):upscale()/2025/02/27/808/n/1922398/26784cf967c0adcd4c0950.54527747_.jpg)
:quality(85):upscale()/2025/02/03/788/n/1922283/010b439467a1031f886f32.95387981_.jpg)
:quality(85):upscale()/2025/01/08/844/n/1922398/cde2aeac677eceef03f2d1.00424146_.jpg)
:quality(85):upscale()/2024/11/27/891/n/1922398/123acea767477facdac4d4.08554212_.jpg)
In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B
Abridge nabbed a $300 million Series E led by a16z, months after it closed its previous $250 million fundraise. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software.
Abridge nabbed a $300 million Series E led by a16z, months after it closed its previous $250 million fundraise. The 7-year-old Abridge is widely considered to be the leader in the increasingly crowded AI-powered medical scribe market, largely due to its early entry and integration with Epic Systems, the dominant health record software.
What's Your Reaction?
News Moderator - Tomas Kauer
https://www.tomaskauer.com/
:quality(85):upscale()/2024/12/02/919/n/1922398/2b4b75f6674e20edcc99c3.42112799_.jpg)
